Reappraisal of GIK in Acute STEMI by Pre-hospital Administration
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 334 participants.
Also called NCT02591927
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 334 participants
- Sponsor
- Centre Hospitalier Universitaire Vaudois
- Registry
-
NCT02591927
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Switzerland
- Registry status
- Unknown status
Technical summary
Registry record NCT02591927. Randomized; quadruple masking; primary purpose treatment. Start 2016-02 (registry gives no type); primary completion 2019-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reappraisal of GIK in Acute STEMI by Pre-hospital Administration
- Acronym
- REAGIK-STEMI
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Glucose-Insulin-Potassium
- Intervention (Drug)
- Glucose 5%
- Lead sponsor
- Centre Hospitalier Universitaire Vaudois
Record details
- Record id
cardio:ct-nct02591927- Content hash
06e0396322ddeefeb3cbdd8a6fc116a398db8f8e0c306f27a4da7df9ff65c752